Letter to the Editor
Pneumococcal Vaccine Eligibility Misconception
Abstract
To the Editor: Oldfield and Stewart did an excellent job discussing 10 misconceptions regarding adult vaccination administration.1 Recommendation 4, ‘‘Both pneumococcal polysaccharide vaccine and pneumococcal conjugate vaccine are indicated in healthy adults older than 65 years,’’ however, contained some errors in the text and accompanying figure.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
References
1. Oldfield BJ, Stewart RW. 10 practice recommendations in adult vaccination administration. South Med J 2016;109:87-90.
2. Kobayashi M, Bennett NM, Gierke R, et al. Intervals between PCV13 and PPSV23 vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2015;64:944-947.
3. Centers for Disease Control and Prevention. PCV13 (pneumococcal conjugate) vaccine. Recommendations, Scenarios and Qɪ for healthcare professionals about PCV13 for adults. http://www.cdc.gov/vaccines/vpd-vac/pneumo/vac-PCV13-adults.htm. Published September 3, 2015. Accessed March 8, 2016.
